Bayer Cipro For Anthrax Prophylaxis Would Be Alternative To Penicillin - FDA
Executive Summary
Bayer Cipro (ciprofloxacin) should be considered an alternative to penicillin and doxycycline for the treatment of post-exposure prophylaxis of anthrax, FDA told the Anti-Infective Drug Products Advisory Committee during a July 28 review of the drug.
You may also be interested in...
CDER Antibioterrorism Efforts Focus On Small Pox And Plague
The Center for Drug Evaluation & Research's antibioterrorism efforts are focusing on development of drugs to counter small pox and plague.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011